The experimental approaches based on the sorting of CD25−T-cells do not provide supportive evidence for a de novo induction of pTregs, and do not exclude a possibility of tumor-driven activation and expansion of CD4+CD25−Foxp3+ thymus-derived tTregs. Here, CD4 is linked to neoplasm.